BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17351043)

  • 1. Differential Bvg phase-dependent regulation and combinatorial role in pathogenesis of two Bordetella paralogs, BipA and BcfA.
    Sukumar N; Mishra M; Sloan GP; Ogi T; Deora R
    J Bacteriol; 2007 May; 189(10):3695-704. PubMed ID: 17351043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein.
    Stockbauer KE; Fuchslocher B; Miller JF; Cotter PA
    Mol Microbiol; 2001 Jan; 39(1):65-78. PubMed ID: 11123689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of the Bordetella BvgA protein: transcriptional activation and repression of the Bordetella bronchiseptica bipA promoter.
    Mishra M; Deora R
    J Bacteriol; 2005 Sep; 187(18):6290-9. PubMed ID: 16159761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity.
    Irie Y; Yuk MH
    FEMS Microbiol Lett; 2007 Oct; 275(2):191-8. PubMed ID: 17714485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bvg-repressed gene brtA, encoding biofilm-associated surface adhesin, is expressed during host infection by Bordetella bronchiseptica.
    Nishikawa S; Shinzawa N; Nakamura K; Ishigaki K; Abe H; Horiguchi Y
    Microbiol Immunol; 2016 Feb; 60(2):93-105. PubMed ID: 26756546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BvgA functions as both an activator and a repressor to control Bvg phase expression of bipA in Bordetella pertussis.
    Williams CL; Boucher PE; Stibitz S; Cotter PA
    Mol Microbiol; 2005 Apr; 56(1):175-88. PubMed ID: 15773988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens.
    Cotter PA; Miller JF
    Mol Microbiol; 1997 May; 24(4):671-85. PubMed ID: 9194696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity in the Bordetella virulence regulon: transcriptional control of a Bvg-intermediate phase gene.
    Deora R; Bootsma HJ; Miller JF; Cotter PA
    Mol Microbiol; 2001 May; 40(3):669-83. PubMed ID: 11359572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the role of the Bvg intermediate phase in Bordetella pertussis during experimental respiratory infection.
    Vergara-Irigaray N; Chávarri-Martínez A; Rodríguez-Cuesta J; Miller JF; Cotter PA; Martínez de Tejada G
    Infect Immun; 2005 Feb; 73(2):748-60. PubMed ID: 15664913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica.
    Yuk MH; Harvill ET; Miller JF
    Mol Microbiol; 1998 Jun; 28(5):945-59. PubMed ID: 9663681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for phenotypic bistability resulting from transcriptional interference of bvgAS in Bordetella bronchiseptica.
    Mason E; Henderson MW; Scheller EV; Byrd MS; Cotter PA
    Mol Microbiol; 2013 Nov; 90(4):716-33. PubMed ID: 24007341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bipA alleles within and across Bordetella species.
    Fuchslocher B; Millar LL; Cotter PA
    Infect Immun; 2003 Jun; 71(6):3043-52. PubMed ID: 12761081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the virulence control systems of Bordetella pertussis and Bordetella bronchiseptica.
    Martínez de Tejada G; Miller JF; Cotter PA
    Mol Microbiol; 1996 Dec; 22(5):895-908. PubMed ID: 8971711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the filamentous hemagglutinin-like protein FhaS in Bordetella bronchiseptica.
    Julio SM; Cotter PA
    Infect Immun; 2005 Aug; 73(8):4960-71. PubMed ID: 16041011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic modulation of the virulent Bvg phase is not required for pathogenesis and transmission of Bordetella bronchiseptica in swine.
    Nicholson TL; Brockmeier SL; Loving CL; Register KB; Kehrli ME; Stibitz SE; Shore SM
    Infect Immun; 2012 Mar; 80(3):1025-36. PubMed ID: 22158743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer membrane protein OmpQ of Bordetella bronchiseptica is required for mature biofilm formation.
    Cattelan N; Villalba MI; Parisi G; Arnal L; Serra DO; Aguilar M; Yantorno O
    Microbiology (Reading); 2016 Feb; 162(2):351-363. PubMed ID: 26673448
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Yount KS; Jennings-Gee J; Caution K; Fullen AR; Corps KN; Quataert S; Deora R; Dubey P
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308083
    [No Abstract]   [Full Text] [Related]  

  • 18. Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract.
    Preston A; Maxim E; Toland E; Pishko EJ; Harvill ET; Caroff M; Maskell DJ
    Mol Microbiol; 2003 May; 48(3):725-36. PubMed ID: 12694617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bvg virulence control system regulates biofilm formation in Bordetella bronchiseptica.
    Irie Y; Mattoo S; Yuk MH
    J Bacteriol; 2004 Sep; 186(17):5692-8. PubMed ID: 15317773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens.
    Lorenzo-Pajuelo B; Villanueva JL; Rodríguez-Cuesta J; Vergara-Irigaray N; Bernabeu-Wittel M; Garcia-Curiel A; Martínez de Tejada G
    J Clin Microbiol; 2002 Sep; 40(9):3146-54. PubMed ID: 12202545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.